AdNuPARmE1A is an oncoselective conditionally replicating adenovirus type 5

With a unique safety profile, a strong oncolytic activity against both cancer and cancer stem cells, and a synergistic behavior when combined with gemcitabine and nab-paclitaxel through NF-kB stimuli.